Treatment preferences for comorbid obesity and obstructive sleep apnea (PRO-CON OSA) survey: Patient and provider preferences for CPAP and/or tirzepatide

By afschroeder • February 24, 2026

Schmickl CN, Tripipitsiriwat A, Mokhlesi B, Mallampalli M, Nokes B, Kundel V, Page K, Finch C, Donovan L, Tadros M, Aysola RS, Zinchuk A, Zvenyach T, Safwan Badr M, Patel SR, Orr JE, Owens RL, Lindsell C, Martin JL, Malhotra A; PARADIGM-SLEEP Investigators. Treatment preferences for comorbid obesity and obstructive sleep apnea (PRO-CON OSA) survey: Patient and provider preferences for CPAP and/or tirzepatide. J Clin Sleep Med. 2026 Feb 23;22(1):35. doi: 10.1007/s44470-025-00024-0. PMID: 41731227.

Tags: Comparative Effectiveness, Continuous positive airway pressure (CPAP), Obesity, obstructive sleep apnea, patient preference, Publications, Pulmonary, Critical Care & Sleep Medicine, survey, tirzepatide

Waitlist mortality and post transplant survival amongst non-extracorporeal membrane oxygenation high-urgency heart transplant recipients before and after the 2018 policy change

White JP, Song J, Kim ST, Zappacosta H, Cho PD, McKay S, Girish A, Abramov A, Daniel M, Telesca D, Husain M, Ardehali A. Waitlist[...]

Evaluating the 2023 safety-net kidney policy: Eligibility and outcomes of heart transplant recipients in the United States

Zappacosta H, Daniel M, Tan N, Cho PD, Song J, White JP, Ardehali A. Evaluating the 2023 safety-net kidney policy: Eligibility and outcomes of heart[...]

Results from a Phase II Single Arm Trial Evaluating the Safety and Efficacy of Anhydrous Enol-Oxaloacetate on Improving Cognitive Complaints in Breast Cancer Survivors

Ganz PA, Van Dyk K, Crespi CM, Petersen L, Sedrak MS, Bower JE. Results from a Phase II Single Arm Trial Evaluating the Safety and[...]